zika
viru
zikv
outbreak
south
america
specif
pathogen
outcom
highlight
need
new
antivir
substanc
broadspectrum
activ
react
quickli
unexpect
outbreak
emerg
viral
pathogen
recent
natur
compound
silvestrol
isol
plant
aglaia
foveolata
found
potent
antivir
effect
strand
rnaviru
ebola
viru
well
coronaand
picornavirus
strand
rnagenom
antivir
activ
base
impair
translat
viral
rna
inhibit
deadbox
rna
helicas
eukaryot
initi
requir
unwind
structur
region
utr
sever
protooncogen
therebi
facilit
translat
zika
viru
flaviviru
positivestrand
rnagenom
harbor
cap
utr
distinct
secondari
structur
element
therefor
investig
effect
silvestrol
zikv
replic
cell
primari
human
hepatocyt
two
differ
zikv
strain
use
infect
cell
primari
human
hepatocyt
silvestrol
potenti
exert
signific
inhibit
zikv
replic
analyz
strain
even
though
ancestor
strain
uganda
less
sensit
silvestrol
data
might
contribut
identifi
host
factor
involv
control
zikv
infect
help
develop
antivir
concept
use
treat
varieti
viral
infect
without
risk
resist
host
protein
target
recent
outbreak
zikv
brazil
associ
sever
neurolog
effect
like
syndrom
microcephali
newborn
zikv
infect
occur
pregnanc
prompt
consid
zikv
infect
public
health
emerg
intern
concern
pheic
highlight
need
effici
welltoler
antivir
therapi
emerg
infecti
diseas
sever
patholog
effect
present
patient
infect
origin
isol
uganda
firstli
appear
outbreak
french
polynesia
high
mutat
rate
rnavirus
like
zikv
offer
chanc
develop
escap
mutant
strain
resist
drug
target
viral
protein
therefor
promis
strategi
target
host
protein
essenti
viral
life
cycl
underli
high
viral
mutat
rate
silvestrol
natur
compound
rocagl
famili
isol
plant
aglaia
foveolata
identifi
specif
inhibitor
deadbox
rna
helicas
eukaryot
initi
part
heterotrimer
translat
initi
complex
togeth
cap
bind
protein
scaffold
protein
complex
regul
translat
recruit
ribosom
utr
mani
mrna
bind
gpppn
cap
structur
helicas
unwind
rna
secondari
structur
creat
bind
platform
preiniti
complex
silvestrol
select
bind
result
deplet
complex
due
increas
affin
bound
mrna
substrat
thu
abolish
translat
silvestrol
exhibit
antitumor
activ
mani
preclin
model
without
show
major
toxic
side
effect
propos
mechan
silvestrol
inhibit
translat
shortliv
key
protooncogen
cmyc
whose
mrna
utr
extend
includ
region
stabl
rna
secondari
structur
requir
unwind
creat
bind
platform
preiniti
complex
moreov
silvestrol
lead
increas
surviv
rate
sever
xenograft
mous
model
thu
describ
potenti
novel
anticanc
drug
addit
two
recent
studi
antivir
effect
silvestrol
ebola
corona
picornavirus
report
system
silvestrol
inhibit
translat
viral
mrna
extend
structur
utr
ebola
viru
coronaviru
cap
depend
translat
picornaviru
translat
via
intern
ribosom
entri
site
ire
given
fact
rocagl
silvestrol
inhibit
translat
cap
mrna
extend
utr
zikv
genom
repres
rna
featur
studi
aim
investig
effect
silvestrol
translat
replic
two
zikv
strain
materi
method
human
cell
cultur
dmem
supplement
gl
glucos
fectal
calf
serum
fc
mm
lglutamin
uml
penicillin
streptomycin
cell
seed
multiwel
plate
h
later
infect
zikv
strain
uganda
u
kindli
provid
european
viru
archiv
zikv
french
polynesia
fp
kindli
provid
prof
didier
musso
institut
loui
papeet
tahiti
multipl
infect
moi
substanc
silvestrol
medchemexpress
llc
puriti
dmso
genaxxon
bioscienc
puriti
present
respect
dilut
inoculum
cell
wash
warm
pb
h
h
h
pi
cover
fresh
dmem
supplement
respect
substanc
concentr
ensur
presenc
silvestrol
whole
time
cours
h
h
h
pi
cell
wash
pb
harvest
peqgold
trifast
peqlab
biotechnologi
gmbh
erlangen
germani
rna
isol
ripabuff
protein
isol
supernat
harvest
determin
extracellular
viral
rna
particl
zika
viru
zikv
emerg
mosquitoborn
viru
genu
flaviviru
within
flavivirida
famili
close
relat
flavivirus
like
dengu
viru
west
nile
viru
yellow
fewer
viru
transmit
mosquito
caus
sever
patholog
effect
infect
individu
zikv
genom
strand
ssrna
kb
highli
structur
untransl
region
utr
end
predict
form
hairpin
structur
essenti
viral
replic
translat
genom
act
viral
mrna
singl
open
read
frame
directli
translat
polyprotein
amino
acid
africa
french
polynesia
strain
respect
polyprotein
coand
posttransl
process
viral
host
proteas
three
structur
protein
capsid
premembran
envelop
seven
nonstructur
protein
viral
rnadepend
rna
polymeras
possess
addit
methyltransferas
domain
introduc
essenti
cap
viral
rna
primari
human
hepatocyt
phh
isol
cultiv
describ
infect
treatment
phh
perform
accord
experi
intracellular
rna
isol
use
peqgold
trifast
peqlab
biotechnologi
gmbh
accord
manufactur
instruct
extracellular
rna
isol
cell
cultur
supernat
min
centrifug
g
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
follow
manufactur
instruct
extracellular
zikv
rna
quantifi
roch
use
zika
viru
detect
kit
tib
molbiol
berlin
germani
togeth
lightcycl
multiplex
rna
viru
mastermix
roch
basel
switzerland
accord
manufactur
protocol
revers
transcript
intracellular
rna
perform
describ
cdna
quantifi
roch
use
sybr
green
mastermix
thermo
fisher
scientif
waltham
usa
follow
primer
zikvfwd
agatcccggctgaaacactg
zikvrev
ttgcaaggtccatctgtccc
aaagctgtcatcgtgaagaac
gctgctactttgcgggggtag
amount
zikv
rna
normal
amount
transcript
cell
viabil
assess
use
prestoblu
cell
viabil
reagent
thermo
fisher
scientif
describ
addit
lactat
dehydrogenas
ldh
releas
quantifi
ldh
cytotox
detect
kit
clontech
mountain
view
ca
usa
accord
manufactur
protocol
ldhreleaseassay
perform
dmem
reduc
amount
fc
lower
measur
background
ldh
activ
supernat
cell
treat
triton
serv
control
refer
normal
viabil
phh
assess
alt
alanin
aminotransferas
activ
measur
cell
cultur
supernat
reflotron
plu
roch
respect
gpt
alt
test
strip
accord
manufactur
protocol
ripalys
use
perform
sdspage
western
blot
analysi
describ
specif
antibodi
use
detect
protein
biofront
technolog
tallahasse
fl
usa
dilut
detect
specif
antibodi
sigma
aldrich
st
loui
mo
usa
dilut
serv
load
control
specif
antibodi
use
detect
santa
cruz
mvp
lrp
santa
cruz
biotechnolog
heidelberg
germani
abcam
describ
refer
densitometri
scan
membran
irdyecoupl
secondari
antibodi
dilut
quantifi
softwar
imag
studio
licor
lincoln
ne
usa
titer
determin
cell
cultur
supernat
plaqu
assay
perform
vero
cell
seed
plate
cellswel
infect
h
later
cell
cultur
supernat
serial
dilut
dmem
h
pi
cell
wash
pb
cover
c
prewarm
dmem
contain
agaros
min
room
temperatur
plate
incub
h
c
visual
plaqu
agaros
remov
cell
fix
formaldehyd
pb
min
room
temperatur
stain
min
crystal
violet
ethanol
cell
wash
water
titer
pfuml
determin
count
plaqu
well
respect
dilut
cell
grown
cover
slide
fix
formaldehyd
pb
min
room
temperatur
cell
permeabil
triton
pb
min
room
temperatur
block
bsa
pb
min
room
temperatur
cell
stain
antibodi
biofront
technolog
dilut
afterward
secondari
antibodi
thermo
fisher
scientif
h
room
temperatur
humid
chamber
secondari
antibodi
dilut
supplement
dapi
visual
nuclei
final
cell
mount
mowiol
microscop
slide
immunofluoresc
stain
analyz
use
confoc
laser
scan
microscop
clsm
meta
zen
softwar
carl
zeiss
oberkochen
germani
softwar
biotek
winooski
vt
usa
condit
amount
zikv
posit
cell
least
four
field
view
three
experi
quantifi
result
present
mean
standard
error
mean
sem
least
three
independ
experi
signific
result
analyz
unpair
twotail
student
test
use
graphpad
prism
version
window
graphpad
softwar
san
diego
ca
usa
figur
statist
signific
compar
dmso
control
group
statist
signific
repres
figur
follow
ns
signific
p
p
p
p
p
previou
studi
silvestrol
use
treatment
ebola
viru
ebov
infect
concentr
nm
determin
work
concentr
silvestrol
cell
first
analyz
metabol
activ
cell
treat
differ
concentr
silvestrol
h
prestoblu
assay
silvestrol
exhibit
concentrationdepend
inhibit
cell
metabol
start
concentr
low
nm
figur
rule
cytotox
effect
silvestrol
ldh
releas
assay
perform
quantifi
activ
ldh
supernat
releas
dead
cell
none
three
test
silvestrol
concentr
cytotox
effect
reflect
increas
ldh
activ
detect
h
h
cytotox
effect
observ
nm
nm
concentr
case
cell
treat
nm
silvestrol
increas
ldh
activ
detect
case
incub
period
h
weak
cytotox
effect
detect
lower
concentr
silvestrol
nm
nm
treatment
nm
silvestrol
associ
cytotox
figur
although
still
high
number
viabl
intact
cell
reflect
intact
nuclei
dapi
stain
figur
data
demonstr
silvestrol
affect
cellular
metabol
cancer
cell
line
timeand
dosedepend
manner
exert
moder
cytotox
effect
higher
concentr
h
h
investig
potenti
antivir
effect
silvestrol
zikv
life
cycl
cell
infect
two
zikv
strain
moi
subsequ
treat
silvestrol
h
zikv
strain
uganda
zikv
u
show
neuropatholog
effect
patient
compar
zikv
strain
zikv
fp
french
polynesia
first
strain
associ
microcephali
base
data
cytotox
viabil
assay
accord
previou
studi
silvestrol
use
concentr
nm
impact
viral
life
cycl
analyz
immunofluoresc
microscopi
use
antiserum
figur
c
quantif
immunofluoresc
microscopi
reveal
zikv
strain
french
polynesia
decreas
number
zikvposit
cell
fluoresc
intens
evidenc
stain
treatment
silvestrol
h
h
figur
signific
effect
could
observ
zikv
uganda
strain
except
nm
silvestrol
h
figur
data
indic
silvestrol
exert
inhibitori
effect
spread
zikv
infect
cell
detail
analysi
effect
silvestrol
zikv
life
cycl
amount
intraand
extracellular
zikvspecif
rna
determin
realtim
pcr
rtqpcr
isol
uganda
isol
u
french
polynesia
isol
fp
strong
decreas
intraand
extracellular
amount
zikvgenom
observ
infect
cell
incub
nm
nm
three
analyz
point
time
h
h
h
interestingli
strict
doseeffect
relat
sinc
weaker
intracellular
viral
rna
see
figur
b
almost
effect
extracellular
viral
rna
see
figur
observ
silvestrol
appli
nm
concentr
viral
genom
directli
correspond
infecti
viral
particl
impact
silvestrol
treatment
number
releas
viral
particl
determin
plaqu
assay
vero
cell
isol
strict
doseeffect
relat
case
cell
infect
french
polynesia
isol
nm
nm
silvestrol
compar
control
dmsotreat
cell
decreas
number
releas
viral
particl
observ
h
treatment
h
nm
silvestrol
effici
decreas
titer
signific
effect
observ
nm
silvestrol
similar
pictur
observ
case
cell
infect
uganda
strain
treatment
lead
reduct
amount
releas
viral
particl
figur
f
observ
lack
strict
doseeffect
relat
might
reflect
equilibrium
silvestrol
action
one
hand
directli
affect
zikv
life
cyclerepl
hand
affect
antivir
defens
mechan
host
cell
context
consid
silvestrol
inhibitor
affect
one
hand
translat
viral
rna
hand
translat
varieti
host
factor
factor
could
includ
rnase
proteasom
lysosom
autophagosom
protein
activ
trigger
degrad
viral
genom
viral
protein
impair
stabil
ie
viral
genom
consequ
could
compens
inhibitori
effect
silvestrol
part
viral
life
cycl
taken
togeth
data
show
silvestroldepend
effect
zikv
life
cycl
follow
strict
doseeffect
relat
cell
nm
nm
silvestrol
exert
strong
inhibit
zikv
replic
reflect
significantli
reduc
amount
intraand
extracellular
zikv
genom
nm
silvestrol
fail
impair
zikv
replic
like
due
secondari
effect
infect
host
cell
pinpoint
whether
silvestrol
exert
direct
antivir
effect
translat
viral
protein
due
specif
inhibit
deadbox
rna
helicas
western
blot
analysi
infect
silvestroltr
cell
perform
zikv
protein
detect
specif
antibodi
refer
signal
case
lowest
concentr
nm
isolateszikvu
zikvfpaft
h
signific
reduct
detect
may
cell
cultur
infect
zikv
h
see
figur
detect
western
blot
show
moder
signal
result
increas
sem
time
point
howev
h
h
signific
reduct
amount
found
come
along
dosedepend
reduct
oncogen
known
translat
manner
figur
case
nm
silvestrol
isol
strong
reduct
amount
found
three
investig
time
point
describ
strict
doseeffect
relat
thu
isol
treat
nm
almost
reduct
amount
detect
figur
accord
data
describ
show
nm
silvestrol
lead
slight
increas
amount
zikvspecif
rna
result
indic
antivir
effect
silvestrol
observ
cell
concentr
nm
nm
associ
decreas
amount
zikv
protein
shown
western
blot
loss
viral
protein
could
also
relat
inhibit
reinfect
viral
replic
rather
translat
accord
similar
experi
perform
high
moi
moi
even
higher
moi
would
benefici
system
cytopath
effect
zikv
silvestrol
abl
decreas
amount
zikv
rna
protein
concentr
rang
also
high
moi
confirm
mechan
silvestrol
figur
test
whether
effect
specif
capdepend
viral
translat
effect
silvestrol
hepat
c
viru
hcv
use
ire
translat
test
inde
treatment
hcvposit
cell
result
decreas
viral
protein
figur
data
confirm
specif
silvestrol
viral
translat
initi
silvestrol
describ
potenti
anticanc
drug
due
inhibitori
effect
prolifer
varieti
cancer
cell
cell
origin
human
lung
carcinoma
primari
nontransform
cell
use
studi
antivir
effect
silvestrol
zikv
life
cycl
exclud
side
effect
due
anticanc
effect
silvestrol
purpos
primari
human
hepatocyt
phh
two
differ
donor
infect
zikv
fp
subsequ
treat
silvestrol
even
though
physiolog
host
cell
zikv
thought
keratinocyt
neuron
recent
studi
found
zikv
effici
replic
hepatocyt
isol
cultiv
primari
human
hepatocyt
phh
wellestablish
lab
decid
use
cell
cultur
model
human
primari
cell
supernat
harvest
h
h
h
primari
human
hepatocyt
much
resist
silvestrol
nm
silvestrol
test
highest
concentr
amount
viral
genom
quantifi
rtqpcr
number
infecti
viral
particl
quantifi
plaqu
assay
result
analyz
h
show
none
investig
concentr
silvestrol
nm
nm
nm
exhibit
signific
reduct
amount
viral
genom
howev
h
h
strong
signific
reduct
number
releas
viral
genom
observ
figur
c
quantif
number
infecti
viral
particl
supernat
confirm
three
investig
time
point
number
infecti
zikv
particl
strongli
decreas
case
even
detect
limit
reflect
strong
inhibitori
potenti
figur
interestingli
observ
cell
strict
doseeffect
relat
case
cell
treat
nm
silvestrol
zikv
particl
detect
supernat
strongli
reduc
amount
compar
control
alt
activ
supernat
phh
measur
cytotox
detect
limit
ul
sampl
slightli
increas
case
nm
silvestrol
figur
howev
sera
male
human
alt
activ
ul
consid
repres
liver
damag
henc
obtain
alt
activ
ul
correspond
cytotox
address
toxic
silvestrol
primari
cell
detail
brightfield
imag
prestoblu
assay
perform
treat
cell
well
readout
confirm
toxic
effect
nm
silvestrol
phh
h
h
treatment
figur
howev
lower
concentr
toxic
cell
show
remark
reduct
viral
load
data
confirm
specif
inhibit
translat
affect
zikv
replic
complex
interplay
direct
inhibit
viral
life
cycl
one
hand
interfer
cellular
antivir
mechan
hand
zika
viral
genom
strand
ssrna
therefor
serv
directli
templat
protein
biosynthesi
cellular
translat
machineri
zikv
genom
expos
structur
utr
translat
depend
cap
introduc
viral
protein
expect
requir
initi
translat
viral
polyprotein
unwind
rna
secondari
structur
ebov
strand
ssrna
viru
signific
antivir
effect
silvestrol
observ
ebov
system
silvestrol
inhibit
translat
viral
mrna
extend
structur
utr
inde
natur
compound
silvestrol
use
nm
nm
concentr
exert
signific
antivir
effect
zikvinfect
cell
effect
observ
analyz
zika
viru
strain
zikvu
zikvfp
silvestrol
well
character
inhibit
protein
synthesi
data
suggest
translat
zikv
genom
block
silvestrol
prove
inhibitori
effect
silvestrol
translat
use
system
amount
oncogen
determin
western
blot
decreas
concentrationdepend
manner
silvestrol
treatment
figur
futhermor
lack
inhibitori
effect
silvestrol
iresdepend
translat
hcv
underlin
propos
antivir
mechan
silvestrol
case
zikv
figur
zikv
strain
possess
stabl
long
stemloop
structur
utr
secondari
structur
uganda
strain
seem
much
stabl
predict
sever
onlin
tool
show
higher
stabil
would
impli
higher
depend
helicas
activ
initi
translat
uganda
strain
genom
henc
stronger
antivir
effect
silvestrol
would
expect
gener
observ
differ
effect
silvestrol
zikv
uganda
strain
except
quantif
infecti
titer
concern
number
posit
cell
silvestrol
seem
even
less
effect
mention
could
partial
explain
fact
zikvu
repres
earli
isol
might
acquir
cell
cultur
adapt
mutat
therefor
might
better
replic
effici
zikv
strain
isol
therefor
well
adapt
cell
cultur
ancestor
viru
uganda
furthermor
unwind
utr
higher
stabil
may
requir
addit
helicas
activ
inhibit
alon
might
suffici
inhibit
translat
rna
uncov
detail
featur
silvestrolsensit
utr
structur
futur
interest
howev
sensit
readout
via
rtqpcr
clearli
show
signific
antivir
effect
silvestrol
zikv
u
suggest
viral
translat
also
inhibit
strain
investig
specif
observ
effect
cell
viabil
toxic
assay
perform
cell
viabil
assay
prestoblu
assay
measur
metabol
activ
cell
timeand
concentrationdepend
decreas
metabol
activ
observ
silvestrol
figur
accord
former
public
well
microscop
imag
studi
figur
show
decreas
prolifer
tumor
cell
line
silvestrol
howev
cytotox
observ
silvestrol
treatment
ldhreleas
assay
incub
period
figur
expect
inhibit
differ
substanc
show
cytotox
effect
previou
studi
therefor
antivir
effect
silvestrol
zika
viru
time
point
base
cytotox
also
explain
minor
cytostat
effect
moreov
amount
protein
zikv
genom
normal
housekeep
respect
rule
possibl
secondari
effect
specif
silvestrol
zikv
translat
underlin
use
primari
human
hepatocyt
infect
french
polynesia
strain
figur
cell
base
tumor
cell
line
therefor
show
growth
inhibit
silvestrol
increas
alt
activ
morpholog
effect
observ
due
silvestrol
treatment
figur
remark
nm
silvestrol
show
toxic
effect
phh
donor
could
explain
oncogen
predisposit
cell
donor
suffer
hepatocellular
carcinoma
figur
strong
effect
silvestrol
zikv
even
pronounc
cell
cours
first
glanc
lack
clear
doseeffect
relat
surpris
howev
consid
silvestrol
inhibitor
affect
one
hand
translat
viral
rna
hand
translat
cellular
mrna
thu
express
varieti
host
factor
mass
spectrometri
data
cellular
lysat
cell
cellular
major
vault
protein
mvp
identifi
downregul
silvestrol
treatment
submit
confirm
western
blot
immunofluoresc
analysi
show
decreas
amount
mvp
transloc
cytoplasm
perinuclear
region
figur
mvp
suppos
exert
antivir
effect
affect
interferon
type
cytoplasm
signal
decreas
amount
protein
withdraw
mvp
cytoplasm
would
affect
capac
deregul
cytoplasm
antivir
signal
cascad
mvp
part
antivir
interferoncascad
decreas
amount
protein
cytoplasm
could
explain
partial
recoveri
zikv
nm
silvestrol
howev
experi
perform
character
potenti
antivir
effect
mvp
zikv
studi
impact
mvp
zikv
life
cycl
detail
surprisingli
concentrationdepend
effect
silvestrol
cell
infect
compar
high
moi
figur
might
indic
low
moi
infect
antivir
effect
eg
mvp
inhibit
spread
viru
seen
high
moi
reinfect
rare
interestingli
mvp
could
detect
hcvposit
cell
figur
surpris
sinc
cell
bear
mutat
antivir
interferonpathway
eg
rigi
confer
suscept
cell
hcv
line
increas
viral
protein
observ
silvestrol
treatment
cellular
antivir
protein
affect
light
complex
interplay
silvestrol
inhibit
pathogen
host
translat
antivir
protein
direct
applic
silvestrol
clinic
might
difficult
howev
studi
identifi
cellular
factor
target
inhibit
zikv
spread
comparison
antivir
effect
cell
treat
nm
nm
effect
observ
cell
treat
nm
silvestrol
show
lack
doseeffect
relat
atyp
cours
reflect
complex
interplay
direct
effect
zikv
translat
translat
antivir
factor
varieti
host
factor
trigger
antivir
respons
rnase
proteasom
lysosom
autophagosom
protein
translat
antivir
activ
involv
ie
degrad
viral
genom
viral
protein
impair
stabil
viral
genom
consequ
increas
stabil
lead
elev
genom
level
therebi
could
compens
inhibitori
effect
silvestrol
part
viral
life
cycl
impair
translat
taken
togeth
studi
give
evid
silvestrol
potenti
exert
potent
antivir
effect
pathogen
zikv
might
contribut
identifi
host
factor
involv
control
zikv
infect
might
help
develop
antivir
concept
use
treat
varieti
viral
infect
without
risk
resist
host
protein
target
supplementari
materi
follow
avail
onlin
http
figur
silvestrol
inhibit
translat
cell
treat
indic
amount
silvestrol
cell
lysat
indic
time
point
analyz
western
blot
specif
antibodi
figur
